Supernus Pharmaceuticals, Inc. (SUPN)

CIK 1356576 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Supernus Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Sep 11, 2026DEFM14A0001104659-26-107109
Aug 14, 202640001836067-26-000010
Aug 14, 202640001539215-26-000012
Aug 14, 202640001804567-26-000014
Aug 14, 202640001539937-26-000012
Aug 14, 202640001194020-26-000015
Aug 6, 2026SCHEDULE 13G/A0001104659-26-092198
Aug 4, 20264250001193125-26-331036
Aug 3, 20264250001193125-26-330875
Aug 3, 20268-K0001104659-26-089524
Aug 3, 202610-Q0001356576-26-000037
Aug 3, 2026DEFA14A0001104659-26-089427
Aug 3, 20264250001104659-26-089426
Aug 3, 20264250001104659-26-089525
Aug 3, 20268-K0001356576-26-000035
Aug 3, 20264250001104659-26-089848
Aug 3, 2026DEFA14A0001104659-26-089526
Aug 3, 2026DEFA14A0001104659-26-089849
Aug 3, 20268-K0001104659-26-089425
Aug 3, 20268-K0001104659-26-089839
Jul 31, 202640001836067-26-000008
Jul 31, 202640001539937-26-000010
Jul 31, 202640001804567-26-000012
Jul 31, 202640001539215-26-000010
Jul 31, 202640001194020-26-000013